Remedium Lifecare Share Price

Quadrant Future Tek allotment today: Check status, GMP, listing date

IRCTC share steams ahead 5% as Macquarie initiates with 'Outperform'

Lloyds Metals' shares hits new high in weak market; surges 34% in 1 month

BSE SME Fabtech Technologies Cleanrooms soars on listing day

Delta Corp Ltd leads gainers in 'A' group

We write to you in reference to recent media reports claiming that Remedium Lifecare Limited has received an order worth ?8500 crore from Eli Lilly and Company. The reports further suggest that this order marks a significant milestone for our company and the Indian pharmaceutical sector.We would like to categorically state that these reports are entirely speculative and unfounded. Remedium Lifecare Limited has not entered into any such agreement or received any orders from Eli Lilly and Company as mentioned in the media.As a responsible corporate entity we remain committed to providing accurate and timely information to the exchange and our stakeholders in accordance with the applicable regulations. Should there be any material developments or agreements that require disclosure we will notify the exchange in due course.We kindly request BSE to take note of this clarification and advise investors and stakeholders to refrain from relying on unverified media reports.

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we wish to inform you about the following changes in composition of the Board:(a) Ms. Seema Sanei (DIN: 10549952) has tendered her resignation as an Independent Director of the Company with effect from closure of business hours on 03rd January 2025 citing pre-occupation and other personal commitments. Consequently She shall also cease to be a Chairman of the Nomination and Remuneration Committee and Risk Management Committee of the Company.(b) Mr. Pratik Shah (DIN: 06809235) has tendered his resignation as the Independent Director of the Company with effect from closure of business hours on 03rd January 2025 citing pre-occupation and other personal commitments. Consequently he shall also cease to be Member of the Stakeholders Relationship Committee of the Company.

correction of intimation of trading window closure

Intimation of closure of Trading window pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015

Newspaper Publication of Notice of Postal Ballot & Remote E-voting to members pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirements ) Regulation 2015